Philip Morris urges FDA to classify ZYN as modified risk tobacco product (PM:NYSE)
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Philip Morris is seeking modified risk tobacco product classification from the FDA for ZYN. The company has had success with a similar classification for its IQOS product. It is unclear how the FDA will respond to the request for ZYN.